Search Results Search Sort by RelevanceMost Recent Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Virtual Mentor. 2004;6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408. Health Law Aug 2004 Words Count as Much as Deeds Leah Eisenberg and Melissa Junge, MBA Virtual Mentor. 2004;6(8):353-356. doi: 10.1001/virtualmentor.2004.6.8.hlaw1-0408. Policy Forum Aug 2004 Brain Death: At Once "Well Settled" and "Persistently Unresolved" Robert Truog, MD Virtual Mentor. 2004;6(8):357-359. doi: 10.1001/virtualmentor.2004.6.8.pfor1-0408. Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408. Viewpoint Aug 2004 Neuroethics Martha J. Farah Virtual Mentor. 2004;372-375. doi: 10.1001/virtualmentor.2004.6.8.oped2-0408. Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986. Case and Commentary Jul 2021 When Imaging Data Contradict a Patient’s Self-report, How Should Clinicians Proceed? Joyeeta G. Dastidar, MD, MS, HEC-C Patients’ perceptions of how much input they have in making health decisions influence therapeutic alliance and outcomes. AMA J Ethics. 2021;23(7):E524-529. doi: 10.1001/amajethics.2021.524. Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Virtual Mentor. 2004;6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408.
Health Law Aug 2004 Words Count as Much as Deeds Leah Eisenberg and Melissa Junge, MBA Virtual Mentor. 2004;6(8):353-356. doi: 10.1001/virtualmentor.2004.6.8.hlaw1-0408.
Policy Forum Aug 2004 Brain Death: At Once "Well Settled" and "Persistently Unresolved" Robert Truog, MD Virtual Mentor. 2004;6(8):357-359. doi: 10.1001/virtualmentor.2004.6.8.pfor1-0408.
Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408.
Viewpoint Aug 2004 Neuroethics Martha J. Farah Virtual Mentor. 2004;372-375. doi: 10.1001/virtualmentor.2004.6.8.oped2-0408.
Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986.
Case and Commentary Jul 2021 When Imaging Data Contradict a Patient’s Self-report, How Should Clinicians Proceed? Joyeeta G. Dastidar, MD, MS, HEC-C Patients’ perceptions of how much input they have in making health decisions influence therapeutic alliance and outcomes. AMA J Ethics. 2021;23(7):E524-529. doi: 10.1001/amajethics.2021.524.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.